CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 110 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,635,000 | +20.6% | 1,500,000 | +50.0% | 1.78% | +33.9% |
| Q2 2021 | $6,330,000 | -47.5% | 1,000,000 | -31.0% | 1.33% | +37.6% |
| Q2 2020 | $12,067,000 | +1025.7% | 1,448,604 | +936.8% | 0.96% | +761.6% |
| Q1 2020 | $1,072,000 | -89.6% | 139,718 | -85.4% | 0.11% | -89.0% |
| Q1 2019 | $10,310,000 | – | 959,077 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,450,000 | $8,320,500 | 1.17% |
| BVF INC/IL | 6,595,801 | $8,508,583 | 0.23% |
| Bronte Capital Management Pty Ltd. | 925,245 | $1,193,566 | 0.12% |
| Formidable Asset Management, LLC | 318,111 | $410,363 | 0.09% |
| Congress Park Capital LLC | 112,450 | $145,061 | 0.08% |
| Forefront Analytics, LLC | 49,421 | $63,754 | 0.04% |
| Ground Swell Capital, LLC | 10,966 | $14,146 | 0.02% |
| Clearline Capital LP | 196,583 | $253,592 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 81,352 | $104,944 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 2,646,190 | $3,412 | 0.01% |